Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7WVS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,898
Award facts
- Contract value 100% obligated
- $30,897.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,897.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injector medication. The contract, designated as delivery order 4570422098, has an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor providing critical medical products to federal government healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. That IDC enables the company to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical devices to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. Enbrel, a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other autoimmune conditions, represents a specialized pharmaceutical commodity within the company's extensive federal medical procurement portfolio.
Quick answers
Who was awarded contract SPE2DR26F7WVS?
SPE2DR26F7WVS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F7WVS worth?
The government has obligated $30,898 on SPE2DR26F7WVS.
Is contract SPE2DR26F7WVS an order under another contract?
Yes. SPE2DR26F7WVS is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WVS competed?
The extent of competition for SPE2DR26F7WVS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award